Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Adverum Biotechnologies, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- −12 vs. Q3 2021
- Shares held
- 65.9M
- −4.06M (−5.8%) vs. Q3 2021
- Total value
- $115.5M
- −$35.7M (−23.6%) vs. Q3 2021
- New holders
- 14
- 26 more added
- Sold out
- 26
- 39 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 50 | $63.8M |
| Q2 2025 | 59 | $30.1M |
| Q1 2025 | 71 | $69.8M |
| Q4 2024 | 70 | $74.1M |
| Q3 2024 | 77 | $120.2M |
| Q2 2024 | 68 | $117.7M |
| Q1 2024 | 61 | $236.9M |
| Q4 2023 | 61 | $48.3M |
| Q3 2023 | 61 | $97.9M |
| Q2 2023 | 58 | $104.4M |
| Q1 2023 | 55 | $45.0M |
| Q4 2022 | 59 | $33.2M |
| Q3 2022 | 78 | $55.6M |
| Q2 2022 | 77 | $70.0M |
| Q1 2022 | 92 | $82.4M |
| Q4 2021 | 98 | $115.5M |
| Q3 2021 | 110 | $151.2M |
| Q2 2021 | 118 | $280.4M |
| Q1 2021 | 132 | $937.9M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Adverum Biotechnologies, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prudential Financial Inc | 0 | $0 | 0.00% | −173,670−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −133,700−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −120,266−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −88,293−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −65,591−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −60,500−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −57,768−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −34,425−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −54,095−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −53,600−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −42,800−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −26,600−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −26,182−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −23,662−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −16,006−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −14,076−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −13,054−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −7,646−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −3,868−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,736−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,706−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −1,840−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −2,250−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |